Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 51

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
6021038
  • C Sequence analysis of the entire coding region

CMT2A2

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Charcot-Marie-Tooth Neuropathy Type 2A2

(AC) Atlanta Center: Medical Neurogenetics, LLC.
United States
11
  • C Sequence analysis of the entire coding region

Charcot Marie Tooth Type 2A2 (MFN2)

Molecular Genetics Laboratory London Health Sciences Centre
Canada
11
  • C Sequence analysis of the entire coding region

Charcot Marie Tooth - Axonal Neuropathy NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
5041
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Charcot Marie Tooth - Comprehensive NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
5445
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Charcot Marie Tooth Panel

Molecular Genetics Laboratory London Health Sciences Centre
Canada
3017
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Optic Atrophy NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
1816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Mitochondrial Genome Maintenance/Integrity Nuclear Genes NextGen Sequencing (NGS) panel

PreventionGenetics
United States
2722
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

MPZ, MFN2. MLPA testing

Instituto de Medicina Genomica
Spain
52
  • D Deletion/duplication analysis

DNM2, GARS, GDAP1, GJB1, MFN2, MPZ, MTMR2, NEFL, PMP22, PRX. NextGeneDx.Complete sequencing by NGS

Instituto de Medicina Genomica
Spain
1810
  • C Sequence analysis of the entire coding region

MFN2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

MFN2-Related Disorders via the MFN2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories
United States
845637
  • D Deletion/duplication analysis

nucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Mitofusin 2 (MFN2) gene sequencing test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
11
  • C Sequence analysis of the entire coding region

CHARCOT- MARIE TOOTH

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
3432
  • C Sequence analysis of the entire coding region

Charcot-Marie-Tooth neuropathy type 2A2

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing MFN2

CeGaT GmbH
Germany
21
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 51

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.